Cargando…

Comparison of the Serum Level of Cancer Antigen 125 and Human Epididymis Protein 4 in Ovarian Cancer Patients and Healthy Groups in Isfahan City

BACKGROUND: Ovarian cancer is the most common fatal malignancy of the gynecology tract. The purpose of this study was to compare serum levels of tumor markers cancer antigen 125 (CA125) and human epididymis protein 4 (HE4) in both healthy groups and patients with ovarian cancer. MATERIALS AND METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bakrani, Mahnaz, Poor, Kahin Shahani, Mehrzad, Valiollah, Razmi, Nematallah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5672644/ https://www.ncbi.nlm.nih.gov/pubmed/29142887 http://dx.doi.org/10.4103/2277-9175.216778

Ejemplares similares

Multiple biomarkers are more accurate than a combination of carbohydrate antigen 125 and human epididymis protein 4 for ovarian cancer screening
por: Kang, Kyung Nam, et al.
Publicado: (2022)

The Role of Interleukin 6 (IL6), Cancer Antigen—125 (CA-125), and Human Epididymis Protein 4 (HE4) to predict tumor resectability in the advanced epithelial ovarian cancer patients
por: Muhammad, Syamel, et al.
Publicado: (2023)

Diagnostic value of serum human epididymis protein 4 and cancer antigen 125 in the patients with ovarian carcinoma: A protocol for systematic review and meta-analysis
por: Dai, Hai-Ying, et al.
Publicado: (2021)

The Use of Human Epididymis 4 and Cancer Antigen 125 Tumor Markers in the Benign or Malignant Differential Diagnosis of Pelvic or Adnexal Masses
por: Dolgun, Zehra Nihal, et al.
Publicado: (2017)

Diagnostic value of serum human epididymis protein 4, carbohydrate antigen 125 and their combination in endometrial cancer: A meta-analysis
por: Wu, Qi, et al.
Publicado: (2023)

Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and ca125 in predicting epithelial ovarian cancer: A meta-analysis
por: Li, Fake, et al.
Publicado: (2012)

Clinical Usefulness of Cancer Antigen (CA) 125, Human Epididymis 4, and CA72-4 Levels and Risk of Ovarian Malignancy Algorithm Values for Diagnosing Ovarian Tumors in Korean Patients With and Without Endometriosis
por: Shin, Kyung-Hwa, et al.
Publicado: (2020)

Value of detection of serum human epididymis secretory protein 4 and carbohydrate antigen 125 in diagnosis of early endometrial cancer of different pathological subtypes
por: Liu, Xingui, et al.
Publicado: (2015)

Determination Relation of the Zinc Serum Level in Acute Leukemia Adult Patients with Mucositis and Neutropenic Prevalence before and after Treatment in Isfahan' Seyed-Al-Shohada Hospital, 2012–2013
por: Mehrzad, Valiollah, et al.
Publicado: (2018)

Cancer antigen 125 in ovarian cancer surveillance: a decision analysis model
por: Hopkins, M.L., et al.
Publicado: (2007)

Tumour-associated trypsin inhibitor (TATI) and cancer antigen 125 (CA 125) in mucinous ovarian tumours.
por: Mogensen, O., et al.
Publicado: (1990)

Co-Expression of Lewis y Antigen with Human Epididymis Protein 4 in Ovarian Epithelial Carcinoma
por: Zhuang, Huiyu, et al.
Publicado: (2013)

Comparison of glutaminase and cancer antigen 125 for distinguishing benign and malignant ovarian tumors
por: Winarno, Gatot Nyarumenteng Adhipurnawan, et al.
Publicado: (2023)

Situation of children's rights in Isfahan city
por: Ziaei, Shohreh, et al.
Publicado: (2011)

Ovarian Serous Cystadenoma of the Epididymis: A Case Report
por: Pierce, Daniel P, et al.
Publicado: (2023)

Cancer Antigen 125 during Pregnancy in Women without Ovarian Tumor Is Not Often Rising
por: Amampai, Rattapon, et al.
Publicado: (2018)

The Clinical Outcome of Laparoscopic Surgery for Endometriosis on Pain, Ovarian Reserve, and Cancer Antigen 125 (CA-125): A Cohort Study
por: Sarbazi, Fereshte, et al.
Publicado: (2021)

Interaction of CD147 and human epididymis protein 4 promotes invasion and metastasis of ovarian cancer
por: Gao, Lingling, et al.
Publicado: (2021)

Malacoplakia of the Epididymis
por: Kang, Yu Jin, et al.
Publicado: (2013)

Xanthogranuloma of the epididymis
por: Ting, James, et al.
Publicado: (2018)

Testis and Epididymis
Publicado: (2007)

Cancer antigen 125 assessment using carbon quantum dots for optical biosensing for the early diagnosis of ovarian cancer
por: Omer, Walaa E., et al.
Publicado: (2021)

Rising CA-125 (Cancer Antigen 125) Levels: Cancer Recurrence or a Vaccine Reaction?
por: Parkash, Jasmita, et al.
Publicado: (2023)

Bevacizumab plus FOLFOX or FOLFIRI regimens on patients with unresectable liver-only metastases of metastatic colorectal cancer
por: Mehrzad, Valiollah, et al.
Publicado: (2016)

Overexpression of HE4 (human epididymis protein 4) enhances proliferation, invasion and metastasis of ovarian cancer
por: Zhu, Liancheng, et al.
Publicado: (2015)

Human epididymis protein 4 in association with Annexin II promotes invasion and metastasis of ovarian cancer cells
por: Zhuang, Huiyu, et al.
Publicado: (2014)

The fabrication of magnetic particle-based chemiluminescence immunoassay for human epididymis protein-4 detection in ovarian cancer
por: Fu, Xiaoling, et al.
Publicado: (2018)

Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer
por: James, Nicole E., et al.
Publicado: (2018)

Identification and Characterization of Aptamers Targeting Ovarian Cancer Biomarker Human Epididymis Protein 4 for the Application in Urine
por: Hanžek, Antonija, et al.
Publicado: (2023)

Joint Disease Mapping of Breast, Uterine, and Ovarian Cancers in Cities of Isfahan Province from 2005 to 2010 Using Spatial Shared Component Model
por: Nasr, Marzieh, et al.
Publicado: (2021)

Effect of Circulating Antigen on Immunoscintigraphy of Ovarian Cancer Patients Using Anti‐CA125 Monoclonal Antibody
por: Sakahara, Harumi, et al.
Publicado: (1996)

Glucose restriction combined with chemotherapy decreases telomere length and cancer antigen-125 secretion in ovarian carcinoma
por: Antoun, Stephanie, et al.
Publicado: (2020)

Pentoxifylline treatment in patients with cancer cachexia: A double-blind, randomized, placebo-controlled clinical trial
por: Mehrzad, Valiollah, et al.
Publicado: (2016)

Preoperative serum levels of cancer antigen 125 and carcinoembryonic antigen ratio can improve differentiation between mucinous ovarian carcinoma and other epithelial ovarian carcinomas
por: Choi, Ji Hui, et al.
Publicado: (2018)

Dissociation of Testis and Epididymis
Publicado: (1927)

Papillary cystadenoma of the epididymis
por: Lopez, Olga, et al.
Publicado: (2022)

Diseases of the Epididymis and Testicle
por: Morton, Henry H.
Publicado: (1916)

Clinical value of serum human epididymis protein 4 assay in the diagnosis of ovarian cancer: a meta-analysis
por: Yang, Zhijun, et al.
Publicado: (2013)

Identification of high-risk patients by human epididymis protein 4 levels during follow-up of ovarian cancer
por: STEFFENSEN, KARINA DAHL, et al.
Publicado: (2016)

Human Epididymis Protein 4 Promotes Events Associated with Metastatic Ovarian Cancer via Regulation of the Extracelluar Matrix
por: Ribeiro, Jennifer R., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7m4fquug4ujcvvtecgked8hvl7